James Hamilton
Company: Arrowhead Pharmaceuticals Inc.
Job title: Chief of Discovery & Translational Medicine
Seminars:
Targeting Complement C3 and Factor B with siRNA: Concept to Clinic 10:15 am
Lessons learned from discovery and early preclinical complement inhibitor studies Using Complement Factor B inhibitors to target the alternative pathway Evaluating safety, tolerability, PK/PD in C3 and Factor B inhibitors to treat renal diseaseRead more
day: Conference Day One